Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
81-13-0
Molecular formula
C9H19NO4
Molecular weight
205.25 g/mol
Drug class
Alcoholic analogue of D-pantothenic acid (provitamin B5)topical skin protectant and wound-healing agent
Mechanism of action
Converted in tissues to pantothenic acid, a precursor of coenzyme A required for acetylation reactions and lipid metabolism. The exact clinical mechanism of topical skin effects is not fully established; it supports epithelial hydration and repair.
Indications / reported uses
Topical relief of dry, irritated or superficially damaged skin and support of skin-barrier repair; specific indications vary by cream, ointment, spray or other formulation
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Dexpanthenol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dexpanthenol Permitted Daily Exposure (PDE) report (the Dexpanthenol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dexpanthenol Occupational Exposure Limit (OEL) report (the Dexpanthenol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.